As a Clinical Research Specialist with over 12 years of hands-on experience, I have grown through diverse roles — from coordinating BA/BE studies in healthy volunteers to managing global Phase I–III trials across multiple therapeutic areas. My journey reflects a consistent commitment to GCP compliance, data quality, and patient safety, while supporting clinical innovation from site level execution to sponsor oversight. At Dr. Reddy’s Laboratories, I work closely with cross-functional teams and global stakeholders to ensure regulatory-compliant, audit-ready, and milestone-driven trial delivery. I’ve contributed to studies in Dermatology, Gastroenterology, Oncology, Endocrinology, and Psychiatry, taking on responsibilities including site monitoring, TMF management, data query resolution, and IMP logistics. My experience includes: Conducting monitoring visits (onsite & remote) and leading site trainings across India and Europe. Supporting successful regulatory audits (USFDA, EMA, DCGI) with zero critical findings. Oversight of CROs, site feasibility, document reviews (protocol, ICF, IB, CRFs), and EC/Regulatory submissions. Managing over 30+ Phase I–IV trials and 50+ BA/BE studies, with operational excellence and subject safety as top priorities. Having also worked as a Study Manager on global trials in the US and EU, I am passionate about AI-driven trial design, risk-based monitoring, and process automation in clinical operations. My vision is to lead initiatives that blend clinical rigor with digital transformation to bring faster, smarter, and patient-centric research solutions to the world. 🔹 Core Values Integrity in every process I manage. Innovation in problem-solving and execution. Collaboration across teams, cultures, and geographies. 🔸 My Vision I’m passionate about contributing to next-generation clinical trial models, including AI-assisted feasibility, patient recruitment optimization, and data-informed site management. I aspire to transition into global leadership roles where strategic thinking and technology adoption shape tomorrow’s trials.